Concepts (132)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Rheumatic Heart Disease | 7 | 2023 | 167 | 2.460 |
Why?
|
Tanzania | 24 | 2024 | 1379 | 1.720 |
Why?
|
Mitral Valve Stenosis | 5 | 2023 | 348 | 1.440 |
Why?
|
Heart Diseases | 5 | 2024 | 2810 | 1.140 |
Why?
|
Cardiomyopathies | 2 | 2023 | 1946 | 0.750 |
Why?
|
Hypertrophy, Left Ventricular | 2 | 2013 | 853 | 0.570 |
Why?
|
Hypertension | 5 | 2024 | 8595 | 0.460 |
Why?
|
Weight Gain | 1 | 2024 | 2347 | 0.440 |
Why?
|
Echocardiography | 7 | 2024 | 4980 | 0.430 |
Why?
|
Vitamin K | 4 | 2024 | 322 | 0.400 |
Why?
|
Heart Defects, Congenital | 3 | 2024 | 4668 | 0.350 |
Why?
|
Cardiomegaly | 1 | 2012 | 593 | 0.340 |
Why?
|
Coronary Angiography | 1 | 2021 | 4561 | 0.330 |
Why?
|
Acute Kidney Injury | 1 | 2021 | 1936 | 0.310 |
Why?
|
Mitral Valve Insufficiency | 2 | 2022 | 1420 | 0.310 |
Why?
|
Health Resources | 1 | 2014 | 936 | 0.310 |
Why?
|
Contrast Media | 1 | 2021 | 5300 | 0.300 |
Why?
|
Diabetes Mellitus, Type 1 | 2 | 2012 | 3450 | 0.290 |
Why?
|
Cardiomyopathy, Dilated | 2 | 2024 | 819 | 0.290 |
Why?
|
Atrial Fibrillation | 5 | 2024 | 5202 | 0.270 |
Why?
|
Heart Atria | 1 | 2012 | 1344 | 0.270 |
Why?
|
HIV Infections | 4 | 2024 | 17159 | 0.260 |
Why?
|
Prospective Studies | 12 | 2024 | 54265 | 0.250 |
Why?
|
Body Composition | 1 | 2014 | 2418 | 0.250 |
Why?
|
Cross-Sectional Studies | 7 | 2023 | 25927 | 0.240 |
Why?
|
HIV | 1 | 2012 | 1579 | 0.240 |
Why?
|
Ventricular Remodeling | 1 | 2012 | 1259 | 0.230 |
Why?
|
Kansas | 1 | 2023 | 39 | 0.220 |
Why?
|
Heart Failure | 3 | 2024 | 11836 | 0.220 |
Why?
|
Blood Pressure | 3 | 2022 | 8523 | 0.210 |
Why?
|
Cardiovascular Diseases | 3 | 2023 | 15739 | 0.210 |
Why?
|
Adipose Tissue | 1 | 2014 | 3293 | 0.210 |
Why?
|
Young Adult | 9 | 2024 | 58673 | 0.200 |
Why?
|
Anticoagulants | 5 | 2024 | 4899 | 0.200 |
Why?
|
Critical Care | 1 | 2014 | 2699 | 0.200 |
Why?
|
Ventricular Dysfunction, Left | 1 | 2012 | 2130 | 0.190 |
Why?
|
Heart Ventricles | 1 | 2012 | 3811 | 0.170 |
Why?
|
Health Status | 2 | 2023 | 4084 | 0.170 |
Why?
|
Myocardium | 1 | 2012 | 4687 | 0.160 |
Why?
|
Tetralogy of Fallot | 1 | 2024 | 631 | 0.160 |
Why?
|
Female | 25 | 2024 | 391024 | 0.160 |
Why?
|
Adolescent | 12 | 2024 | 87749 | 0.150 |
Why?
|
Middle Aged | 17 | 2024 | 220179 | 0.150 |
Why?
|
Diabetes Mellitus, Type 2 | 2 | 2012 | 12280 | 0.150 |
Why?
|
Neonatal Screening | 1 | 2022 | 596 | 0.150 |
Why?
|
Male | 23 | 2024 | 359427 | 0.150 |
Why?
|
CD4 Lymphocyte Count | 1 | 2024 | 2569 | 0.150 |
Why?
|
Emigration and Immigration | 1 | 2020 | 395 | 0.150 |
Why?
|
Prevalence | 4 | 2023 | 15684 | 0.140 |
Why?
|
Adult | 17 | 2024 | 219843 | 0.140 |
Why?
|
Ambulatory Care Facilities | 1 | 2023 | 926 | 0.140 |
Why?
|
Embolism | 1 | 2020 | 408 | 0.140 |
Why?
|
User-Computer Interface | 1 | 2023 | 1402 | 0.140 |
Why?
|
Humans | 32 | 2024 | 760276 | 0.130 |
Why?
|
Aged | 11 | 2024 | 169002 | 0.130 |
Why?
|
Urban Population | 1 | 2024 | 2021 | 0.130 |
Why?
|
Creatinine | 1 | 2021 | 1907 | 0.130 |
Why?
|
Stroke | 4 | 2023 | 9946 | 0.120 |
Why?
|
Mitral Valve | 1 | 2023 | 1487 | 0.120 |
Why?
|
Child | 7 | 2024 | 79759 | 0.120 |
Why?
|
Anti-Retroviral Agents | 1 | 2024 | 1780 | 0.110 |
Why?
|
Calcinosis | 1 | 2022 | 1478 | 0.110 |
Why?
|
Overweight | 1 | 2024 | 2421 | 0.100 |
Why?
|
Hospitals, Teaching | 1 | 2016 | 1166 | 0.100 |
Why?
|
International Normalized Ratio | 2 | 2024 | 387 | 0.090 |
Why?
|
Waist Circumference | 1 | 2014 | 921 | 0.090 |
Why?
|
Venous Thromboembolism | 1 | 2024 | 1866 | 0.090 |
Why?
|
Length of Stay | 1 | 2024 | 6474 | 0.090 |
Why?
|
Africa South of the Sahara | 2 | 2024 | 743 | 0.090 |
Why?
|
Health Personnel | 1 | 2024 | 3310 | 0.090 |
Why?
|
Hospital Mortality | 1 | 2024 | 5422 | 0.090 |
Why?
|
Systole | 1 | 2012 | 947 | 0.090 |
Why?
|
Diastole | 1 | 2012 | 788 | 0.090 |
Why?
|
Asymptomatic Diseases | 1 | 2012 | 582 | 0.080 |
Why?
|
Cardiac Surgical Procedures | 1 | 2024 | 3618 | 0.080 |
Why?
|
Ultrasonography | 2 | 2012 | 5960 | 0.080 |
Why?
|
Follow-Up Studies | 3 | 2023 | 39256 | 0.080 |
Why?
|
Risk Factors | 6 | 2024 | 74278 | 0.080 |
Why?
|
Blood Flow Velocity | 1 | 2012 | 1375 | 0.080 |
Why?
|
Aged, 80 and over | 3 | 2023 | 58953 | 0.080 |
Why?
|
Anti-HIV Agents | 1 | 2024 | 4492 | 0.070 |
Why?
|
Obesity | 2 | 2024 | 12913 | 0.070 |
Why?
|
Mass Screening | 1 | 2023 | 5422 | 0.070 |
Why?
|
Child, Preschool | 3 | 2024 | 42036 | 0.070 |
Why?
|
Body Mass Index | 1 | 2024 | 12900 | 0.070 |
Why?
|
Forecasting | 1 | 2014 | 2931 | 0.060 |
Why?
|
Diabetes Mellitus | 1 | 2024 | 5884 | 0.060 |
Why?
|
Stroke Volume | 2 | 2024 | 5513 | 0.060 |
Why?
|
Treatment Outcome | 4 | 2024 | 64968 | 0.060 |
Why?
|
Quality of Life | 2 | 2023 | 13301 | 0.060 |
Why?
|
Analysis of Variance | 1 | 2013 | 6242 | 0.060 |
Why?
|
Education, Medical | 1 | 2014 | 1728 | 0.050 |
Why?
|
Incidence | 1 | 2021 | 21379 | 0.050 |
Why?
|
Hematoxylin | 1 | 2022 | 60 | 0.050 |
Why?
|
Eosine Yellowish-(YS) | 1 | 2022 | 69 | 0.050 |
Why?
|
Postoperative Complications | 1 | 2024 | 15684 | 0.050 |
Why?
|
Multivariate Analysis | 1 | 2014 | 12159 | 0.050 |
Why?
|
Retrospective Studies | 6 | 2024 | 80311 | 0.040 |
Why?
|
Hemorrhage | 2 | 2022 | 3606 | 0.040 |
Why?
|
Oximetry | 1 | 2022 | 461 | 0.040 |
Why?
|
Education, Medical, Continuing | 1 | 2024 | 830 | 0.040 |
Why?
|
Infant | 3 | 2024 | 36032 | 0.040 |
Why?
|
Politics | 1 | 2024 | 815 | 0.040 |
Why?
|
Echocardiography, Transesophageal | 1 | 2023 | 1108 | 0.030 |
Why?
|
Delivery of Health Care | 1 | 2014 | 5324 | 0.030 |
Why?
|
South Africa | 1 | 2022 | 1821 | 0.030 |
Why?
|
Pregnancy Complications, Cardiovascular | 1 | 2020 | 516 | 0.030 |
Why?
|
Case-Control Studies | 1 | 2013 | 22040 | 0.030 |
Why?
|
Pregnancy | 3 | 2022 | 29727 | 0.030 |
Why?
|
Fibrosis | 1 | 2022 | 2041 | 0.030 |
Why?
|
Multicenter Studies as Topic | 1 | 2020 | 1723 | 0.030 |
Why?
|
Prenatal Care | 1 | 2021 | 1128 | 0.030 |
Why?
|
Warfarin | 1 | 2022 | 1516 | 0.030 |
Why?
|
Cesarean Section | 1 | 2022 | 1386 | 0.030 |
Why?
|
Infant, Newborn | 2 | 2024 | 26169 | 0.030 |
Why?
|
Recovery of Function | 1 | 2023 | 2983 | 0.030 |
Why?
|
Time Factors | 2 | 2024 | 40141 | 0.020 |
Why?
|
Referral and Consultation | 1 | 2024 | 3598 | 0.020 |
Why?
|
Ventricular Function, Left | 1 | 2024 | 3871 | 0.020 |
Why?
|
Age Distribution | 1 | 2016 | 2893 | 0.020 |
Why?
|
Physical Examination | 1 | 2016 | 1244 | 0.020 |
Why?
|
C-Reactive Protein | 1 | 2022 | 3822 | 0.020 |
Why?
|
Health Knowledge, Attitudes, Practice | 1 | 2024 | 3967 | 0.020 |
Why?
|
Comorbidity | 1 | 2024 | 10553 | 0.020 |
Why?
|
Calcium | 1 | 2022 | 5725 | 0.020 |
Why?
|
Clinical Competence | 1 | 2024 | 4786 | 0.020 |
Why?
|
Sex Factors | 1 | 2020 | 10529 | 0.020 |
Why?
|
Reproducibility of Results | 1 | 2023 | 20045 | 0.020 |
Why?
|
Randomized Controlled Trials as Topic | 1 | 2020 | 10343 | 0.010 |
Why?
|
Risk Assessment | 1 | 2024 | 24086 | 0.010 |
Why?
|
Prognosis | 1 | 2021 | 29640 | 0.010 |
Why?
|
Cohort Studies | 1 | 2022 | 41316 | 0.010 |
Why?
|
Concepts
(132)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(11)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_
Same Department
People in same department with this person.
Explore
_